E-resources
Peer reviewed
-
Imazio, Massimo; Brucato, Antonio; Cemin, Roberto; Ferrua, Stefania; Belli, Riccardo; Maestroni, Silvia; Trinchero, Rita; Spodick, David H; Adler, Yehuda
Annals of internal medicine, 2011-Oct-04, Volume: 155, Issue: 7Journal Article
Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. To evaluate the efficacy and safety of colchicine for the secondary prevention of recurrent pericarditis. Prospective, randomized, double-blind, placebo-controlled multicenter trial. (ClinicalTrials.gov registration number: NCT00128414) SETTING: 4 general hospitals in urban areas of Italy. 120 patients with a first recurrence of pericarditis. In addition to conventional treatment, patients were randomly assigned to receive either placebo or colchicine, 1.0 to 2.0 mg on the first day followed by a maintenance dose of 0.5 to 1.0 mg/d, for 6 months. The primary study end point was the recurrence rate at 18 months. Secondary end points were symptom persistence at 72 hours, remission rate at 1 week, number of recurrences, time to first recurrence, disease-related hospitalization, cardiac tamponade, and rate of constrictive pericarditis. At 18 months, the recurrence rate was 24% in the colchicine group and 55% in the placebo group (absolute risk reduction, 0.31 95% CI, 0.13 to 0.46; relative risk reduction, 0.56 CI, 0.27 to 0.73; number needed to treat, 3 CI, 2 to 7). Colchicine reduced the persistence of symptoms at 72 hours (absolute risk reduction, 0.30 CI, 0.13 to 0.45; relative risk reduction, 0.56 CI, 0.27 to 0.74) and mean number of recurrences, increased the remission rate at 1 week, and prolonged the time to subsequent recurrence. The study groups had similar rates of side effects and drug withdrawal. Multiple recurrences and neoplastic or bacterial causes were excluded. Colchicine is safe and effective for secondary prevention of recurrent pericarditis.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.